Skip to main content
SpringerLink
Log in

Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Semicarbazide-sensitive amine oxidase (SSAO) is present in the plasma membrane of several human tissues, e.g. vascular smooth muscle cell adipocytes, and is also found in human serum. Some previous studies on cultured endothelial cells indicate that cytotoxic metabolites (e.g. hydrogen peroxide, formaldehyde acrolein) formed by serum SSAO may cause endothelial injury and subsequently induce atherosclerosis. To investigate the role of this enzyme in the pathogenesis of macrovascular complications in diabetes, a simple and sensitive radiometric procedure was adapted for human serum measurements. Serum SSAO activity of 35 patients with non-insulin dependent diabetes mellitus (NIDDM) and that of 30 controls was determined using [14C]-benzylamine as substrate. The severity of atherosclerosis was assessed by carotid sonography. Diabetic patients with atherosclerosis exhibited a higher SSAO activity compared to diabetic patients without complications (212.91±90.54 pmol/mg protein/h versus 133.17±65.40 pmol/mg protein/h,P<0.04). In diabetic patients without complications, serum SSAO activity was elevated compared to control subjects (133.17±65.40 pmol/mg protein/h versus 91.79±31.70 pmol/mg protein/h,P<0.01). These results suggest that determination of human serum SSAO activity might be a useful marker in the prognostic evaluation of diabetic angiopathy and atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Callingham B.A., Barrand M.A. (1987): Some properties of semicarbazide-sensitive amine oxidases. J. Neural. Transm. 23 (Suppl.), 37–54.

    CAS  Google Scholar 

  2. Yu P.H., Zuo D.M. (1994): Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity. Biochem. Pharmacol., 47, 1055–1059.

    Article  CAS  PubMed  Google Scholar 

  3. Lyles G.A. (1996): Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int. J. Biochem. Cell. Biol., 28, 259–274.

    Article  CAS  PubMed  Google Scholar 

  4. Raimondi L., Pirisino R., Banchelli G. et al. (1992): Further studies on semicarbazide-sensitive amine oxidase activities (SSAO) of white adipose tissue. Comp. Biochem. Physiol. B, 102, 953–960.

    Article  CAS  PubMed  Google Scholar 

  5. Krieger-Brauer H.I., Kather H. (1995): The stimulus-sensitive H2O2-generating system present in human fat cell plasma membranes is multireceptor-linked and under antagonistic control by hormones and cytokines. Biochem. J., 307, 543–548.

    CAS  PubMed  Google Scholar 

  6. Yu P.H., Zuo D.M. (1993): Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells — possible consequences for diabetes. Diabetes, 42, 594–603.

    Article  CAS  PubMed  Google Scholar 

  7. Yu P.H., Zuo D.M. (1996): Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis, 120, 189–197.

    Article  CAS  PubMed  Google Scholar 

  8. Boomsma F., van Veldhuisen D.J., de Kam P.J. et al. (1997): Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res., 33, 387–391.

    Article  CAS  PubMed  Google Scholar 

  9. Boomsma F., Derkx F.H., van den Meiracker A.H., Manin’t Veld A.J., Schalekamp M.A. (1995): Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin. Sci. (Colch.), 88, 675–679.

    CAS  Google Scholar 

  10. Yu P.H., Zuo D.M. (1992): Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide sensitive amine oxidases isolated from vascular tissues and sera of different species. Biochem. Pharmacol., 43, 307–312.

    Article  CAS  PubMed  Google Scholar 

  11. Bradford M.M. (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem., 72, 248–254.

    Article  CAS  PubMed  Google Scholar 

  12. Yu P.H. (1990): Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol., 42, 882–884.

    CAS  PubMed  Google Scholar 

  13. Lyles G.A., Holt A., Marshal C.M.S. (1990): Further studies on the metabolism of methylamine by semicarbazide sensitive amine oxidase activities in human plasma, umbilical artery and rat aorta. J. Pharm. Pharmacol., 42, 322–338.

    Google Scholar 

  14. North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991): Beneficial effect of carotid endarterectomy in symptomatic patients until length-grade carotid stenosis. N Engl. J. Med., 325, 445–453.

    Article  Google Scholar 

  15. King G.L. (1996): The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann. Med., 28, 427–432.

    Article  CAS  PubMed  Google Scholar 

  16. Stehouwer C.D.A., Lambert J., Donker A.J.M., van Hinsbergh V.W.M. (1997): Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc. Res., 34, 55–68.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacodynamics, Semmelweis University, Nagyvárad tér 4, PO Box 370, H-1445, Budapest, Hungary

    Z. Mészáros & K. Magyar

  2. Third Department of Medicine, Semmelweis University, Nagyvárad tér 4, PO Box 370, H-1445, Budapest, Hungary

    I. Karádi, T. Szombathy & L. Romics

  3. Department of Neurology, Petz Aladár Hospital, Gyõr, Hungary

    A. Csányi

Authors
  1. Z. Mészáros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Karádi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Csányi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Szombathy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Romics
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Magyar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mészáros, Z., Karádi, I., Csányi, A. et al. Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. Eur. J. Drug Metab. Pharmacokinet. 24, 299–302 (1999). https://doi.org/10.1007/BF03190036

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190036

Key words

Search

Navigation